Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs
- Conditions
- Succesful Obturator Nerve BlockBladder TumorBleeding
- Interventions
- Procedure: obturator nerve block
- Registration Number
- NCT04638569
- Lead Sponsor
- Muğla Sıtkı Koçman University
- Brief Summary
Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.
- Detailed Description
The primary aim of this study is to compare the success rates of ONB techniques performed with ultrasound guided or blind technique. Its secondary purpose is to compare the effect of peroperative bleeding and control cystoscopy performed in the postoperative 3rd month on the presence of recurrent tumor.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 116
- ASA I-II patients
- Tumors that disrupt the integrity of the bladder,
- bladder floor tumors,
- coagulation disorders,
- motor in the lower limbs
- with sensory disturbances,
- uncooperative patients,
- Known allergy to local anesthetics
- patients with localized infection at the procedure site
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description obtutaror nerve block with anatomical landmarks obturator nerve block In the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL. Ultrasound-guided obturator nerve block group obturator nerve block The ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle.
- Primary Outcome Measures
Name Time Method Preoperative succesful obturator nerve block operation time peroperative adductor muscle spazm
- Secondary Outcome Measures
Name Time Method peroperative bleeding, Presence of recurrent tumor at postoperative 3rd month 3 months peroperative bledding, Control by cystoscopy in the postoperative 3rd month recurrence tumor size
Trial Locations
- Locations (1)
Mugla Sitki Kocman University
🇹🇷Mugla, Turkey